Recent Research | Page 8 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Stem and progenitor cell alterations in myelodysplastic syndromes Feb 2017 Blood myelodysplastic syndromes (MDS)
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes. Feb 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia Feb 2017 JAMA Oncol acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. Feb 2017 Lancet Haematol myelodysplastic syndromes (MDS)
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia Feb 2017 JAMA Oncol
De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin. Feb 2017 Medicine (Baltimore) aplastic anemia
Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years Jan 2017 Leuk Res myelodysplastic syndromes (MDS)
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab Jan 2017 Ann Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes Jan 2017 Asia Pac J Clin Oncol myelodysplastic syndromes (MDS)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium Jan 2017 Leukemia myelodysplastic syndromes (MDS)